Scot Hasselman

Scot, the co-chair of Reed Smith’s global Life Sciences Health Industry Group, provides knowledgeable and pragmatic advice in high-stakes government investigations and litigation, fast-paced health care transactions, and the development of cutting-edge business arrangements. He serves as a trusted advisor, effective advocate, and creative but practical problem-solver for clients across the health care industry.

Scot’s clients are some of the largest U.S. health care companies, including post-acute providers, institutional and retail pharmacies, managed care organizations, digital health companies, providers of outpatient rehabilitation, optometry and dental services, and investors, including private equity firms.

Scot has considerable experience with the False Claims Act, internal and government investigations, compliance with the federal Anti-Kickback Statute and physician self-referral laws and corollary state laws. Notably, Scot has negotiated numerous government settlements and corporate integrity agreements, including some of the most significant settlements of the past several decades.

He also advises health care providers, life sciences clients, private equity and other industry investors on regulatory due diligence in health care transactions, including mergers and acquisitions.

Clients turn to Scot for his views on the evolution of the health care industry, laws and regulations, and the potential impact on health care and life sciences companies.